• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛患者滥用处方类阿片:来自澳大利亚社区样本的结果。

Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample.

机构信息

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2014 Jan;33(1):27-32. doi: 10.1111/dar.12084. Epub 2013 Nov 20.

DOI:10.1111/dar.12084
PMID:24251668
Abstract

INTRODUCTION AND AIMS

There has been an increase in prescription of opioids for chronic non-cancer pain, and concern exists over possible diversion of prescription opioids to the illicit marketplace. Recent media coverage suggests that elderly patients sell their prescribed opioids for additional income. This study investigated the extent to which an Australian community sample of chronic pain patients prescribed opioids reported supplying their prescribed opioids to others.

DESIGN AND METHODS

Participants living with chronic non-cancer pain and prescribed opioids for their pain (n=952) were recruited across Australia via advertisements at pharmacies. A telephone interview included questions about their pain condition and opioid medication.

RESULTS

Participants had been living with pain for a mean of 14.2 years; most common conditions included chronic back/neck problems and arthritis/rheumatism. Around half (43%) were currently prescribed one opioid, and 55% had been prescribed 2-5 opioids; the most common was oxycodone. Forty-two participants (4%) reported ever supplying prescribed opioids to another person; one participant reported receiving payment. Participants who supplied opioids to others were younger (odds ratio 0.97, 95% confidence interval 0.95-0.99) and engaged in a greater number of aberrant behaviours relating to their opioid medication (odds ratio 1.77, 95% confidence interval 1.45-2.17), including tampering with doses, taking opioids by alternative routes, seeing doctors to obtain extra opioids and refilling prescriptions early.

DISCUSSION AND CONCLUSION

Few people with chronic non-cancer pain divert their opioids to others. Media reports of elderly patients selling their opioids to supplement their income may be reflective of exceptional cases. Future studies may investigate the extent to which other patient groups divert prescription opioids to the illicit marketplace.

摘要

介绍和目的

慢性非癌症疼痛的阿片类药物处方有所增加,人们对处方阿片类药物可能流向非法市场表示担忧。最近的媒体报道表明,老年患者出售他们开的阿片类药物以获得额外收入。本研究调查了澳大利亚社区慢性疼痛患者样本中,有多少患者报告将开的阿片类药物提供给他人。

设计和方法

通过在澳大利亚各地的药店发布广告,招募了患有慢性非癌症疼痛且正在服用阿片类药物治疗疼痛的患者(n=952)。电话访谈包括有关他们的疼痛状况和阿片类药物治疗的问题。

结果

参与者患有疼痛已经平均 14.2 年;最常见的疾病包括慢性背部/颈部问题和关节炎/风湿病。大约一半(43%)目前正在服用一种阿片类药物,55%曾被开过 2-5 种阿片类药物;最常见的是羟考酮。42 名参与者(4%)报告曾将开的阿片类药物提供给他人;一名参与者报告收到过付款。向他人提供阿片类药物的参与者年龄较小(优势比 0.97,95%置信区间 0.95-0.99),并且与他们的阿片类药物治疗相关的异常行为更多(优势比 1.77,95%置信区间 1.45-2.17),包括篡改剂量、通过其他途径服用阿片类药物、看医生获取额外的阿片类药物和提前开处方。

讨论和结论

患有慢性非癌症疼痛的人很少将阿片类药物转移给他人。媒体报道称老年患者出售他们的阿片类药物以补充收入可能反映了特殊情况。未来的研究可能会调查其他患者群体将处方阿片类药物转移到非法市场的程度。

相似文献

1
Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample.慢性疼痛患者滥用处方类阿片:来自澳大利亚社区样本的结果。
Drug Alcohol Rev. 2014 Jan;33(1):27-32. doi: 10.1111/dar.12084. Epub 2013 Nov 20.
2
The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.在开具阿片类药物的慢性非癌性疼痛人群社区样本中对乙酰氨基酚(扑热息痛)的使用情况。
Int J Clin Pract. 2015 Nov;69(11):1366-76. doi: 10.1111/ijcp.12716. Epub 2015 Aug 13.
3
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.美国介入性疼痛医师学会(ASIPP)慢性非癌痛阿片类药物处方责任指南:第一部分——证据评估。
Pain Physician. 2012 Jul;15(3 Suppl):S1-65.
4
The characteristics of a cohort who tamper with prescribed and diverted opioid medications.篡改处方和被转移的阿片类药物的队列特征。
J Subst Abuse Treat. 2015 Nov;58:51-61. doi: 10.1016/j.jsat.2015.06.001. Epub 2015 Jun 24.
5
Reimbursement of analgesics for chronic pain.慢性疼痛镇痛药物的报销。
Tidsskr Nor Laegeforen. 2012 Nov 27;132(22):2489-93. doi: 10.4045/tidsskr.11.1214.
6
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.慢性非癌痛患者使用大麻对阿片类药物处方的影响:一项为期 4 年的前瞻性队列研究结果。
Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.
7
Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain.在为慢性非癌痛开具阿片类药物的人群中,与潜在非医疗性阿片类药物使用指标相关的因素。
Drug Alcohol Rev. 2020 Feb;39(2):128-134. doi: 10.1111/dar.13021. Epub 2019 Dec 16.
8
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.评估奥施康定(oxycodone)改良版对阿片类药物篡改、不遵医嘱和滥用的潜在影响:国家阿片类药物滥用预防(NOMAD)研究方案。
Addiction. 2015 Feb;110(2):226-37. doi: 10.1111/add.12746. Epub 2014 Oct 30.
9
Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.慢性疼痛患者中药物性阿片类药物的使用与依赖:在疼痛与阿片类药物治疗(POINT)队列中观察到的关联
Pain Med. 2015 Sep;16(9):1745-58. doi: 10.1111/pme.12773. Epub 2015 May 22.
10
Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?长期按处方服用阿片类药物的使用者是否比未使用者有更高的物质使用问题发生率?
Pain Med. 2007 Nov-Dec;8(8):647-56. doi: 10.1111/j.1526-4637.2006.00200.x.

引用本文的文献

1
Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour.在澳大利亚全科医疗环境中,针对开具阿片类药物治疗慢性疼痛的患者,使用计划行为理论对处方阿片类药物使用障碍进行诊断和管理:一项定性研究。
BMC Prim Care. 2024 Jul 3;25(1):236. doi: 10.1186/s12875-024-02474-6.
2
Potential for Harm Associated with Discharge Opioids After Hospital Stay: A Systematic Review.出院后使用阿片类药物可能带来的危害:系统评价。
Drugs. 2020 Apr;80(6):573-585. doi: 10.1007/s40265-020-01294-z.
3
Counseling interactions between patients living with persistent pain and pharmacists in Australia: are we on the same page?
澳大利亚慢性疼痛患者与药剂师之间的咨询互动:我们观点一致吗?
J Pain Res. 2019 Aug 5;12:2441-2455. doi: 10.2147/JPR.S199017. eCollection 2019.
4
The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.阿片类药物治疗的风险:来自安全网诊所的初级保健从业者和患者的观点。
Subst Abus. 2017 Apr-Jun;38(2):213-221. doi: 10.1080/08897077.2017.1296524. Epub 2017 Apr 10.
5
Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.2002年至2014年美国12至34岁人群中处方阿片类药物使用障碍及海洛因使用情况
Addict Behav. 2017 Feb;65:236-241. doi: 10.1016/j.addbeh.2016.08.033. Epub 2016 Aug 30.
6
OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol.OPAL:一项关于阿片类镇痛药减轻急性脊柱疼痛患者疼痛严重程度的随机、安慰剂对照试验。试验方案。
BMJ Open. 2016 Aug 24;6(8):e011278. doi: 10.1136/bmjopen-2016-011278.
7
GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.γ-羟基丁酸的药理学与毒理学:急性中毒、法医案例中的血液和尿液浓度以及戒断综合征的治疗
Curr Neuropharmacol. 2015 Jan;13(1):47-70. doi: 10.2174/1570159X13666141210215423.